Abbvie Inc. vs Bio-Techne Corp.
ABBV vs TECH — side-by-side comparison from reported financials. ABBV leads 6, TECH leads 6 of 12 comparable metrics.
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
Bio-Techne Corp.
TECH · Healthcare
$72.44-0.01%Strong
| Metric | ABBV | TECH |
|---|---|---|
| Price | $276.43 | $72.44 |
| Market cap | $488B | $11.4B |
| Revenue (TTM) | $64.4B | $1.22B |
| Revenue growth | +1.8% | +2.3% |
| Net margin | 9.8% | 15.0% |
| Free cash flow | $18.2B | $263M |
| Net cash (debt) | ($56.2B) | ($23.6M) |
| 1-year price return | +19.8% | +20.9% |
| P/E | 77.4 | 62.5 |
| P/E vs own history (cheap-side %) | 23% | 14% |
| Dividend yield | 2.45% | 0.44% |
| Return on equity | 96% | 9% |
| Altman Z-score | 2.33 | 15.94 |
| CV checks passed | 9 of 11 | 8 of 11 |
| Employees | 57,000 | 3,000 |
Full résumé-style profiles: ABBV CV · TECH CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.